Global Companion Diagnostic Tests Market Growth (Status and Outlook) 2020-2025


Jan, 2021 | Report ID: 166833 | 119 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Companion Diagnostic Tests market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Companion Diagnostic Tests business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostic Tests market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Companion Diagnostic Tests, covering the supply chain analysis, impact assessment to the Companion Diagnostic Tests market size growth rate in several scenarios, and the measures to be undertaken by Companion Diagnostic Tests companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

Protein Detection

DNA Detection

Hybridization

Biomarker

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

Pharmaceutical and Biotechnology Companies

Medical Device Companies

Research Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

F. Hoffman LA Roche Ltd.

QIAGEN, Illumina, Inc.

Agilent Technologies, Inc.

Genomic Health, Inc.

Abbott

Siemens Healthcare GmBH

BioMerieux SA, BioGenex

Thermo Fisher Scientific, Inc.

AGENDIA NV

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Companion Diagnostic Tests market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Companion Diagnostic Tests market by identifying its various subsegments.

Focuses on the key global Companion Diagnostic Tests players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Companion Diagnostic Tests with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Companion Diagnostic Tests submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Companion Diagnostic Tests Market Size 2015-2025

2.1.2 Companion Diagnostic Tests Market Size CAGR by Region

2.2 Companion Diagnostic Tests Segment by Type

2.2.1 Protein Detection

2.2.2 Protein Detection

2.2.3 Hybridization

2.2.4 Biomarker

2.2.5 Others

2.3 Companion Diagnostic Tests Market Size by Type

2.3.1 Global Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

2.3.2 Global Companion Diagnostic Tests Market Size Growth Rate by Type (2015-2020)

2.4 Companion Diagnostic Tests Segment by Application

2.4.1 Pharmaceutical and Biotechnology Companies

2.4.2 Medical Device Companies

2.4.3 Research Institutes

2.5 Companion Diagnostic Tests Market Size by Application

2.5.1 Global Companion Diagnostic Tests Market Size Market Share by Application (2015-2020)

2.5.2 Global Companion Diagnostic Tests Market Size Growth Rate by Application (2015-2020)

3 Global Companion Diagnostic Tests by Players

3.1 Global Companion Diagnostic Tests Market Size Market Share by Players

3.1.1 Global Companion Diagnostic Tests Market Size by Players (2018-2020)

3.1.2 Global Companion Diagnostic Tests Market Size Market Share by Players (2018-2020)

3.2 Global Companion Diagnostic Tests Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Companion Diagnostic Tests by Regions

4.1 Companion Diagnostic Tests Market Size by Regions

4.2 Americas Companion Diagnostic Tests Market Size Growth

4.3 APAC Companion Diagnostic Tests Market Size Growth

4.4 Europe Companion Diagnostic Tests Market Size Growth

4.5 Middle East & Africa Companion Diagnostic Tests Market Size Growth

5 Americas

5.1 Americas Companion Diagnostic Tests Market Size by Countries

5.2 Americas Companion Diagnostic Tests Market Size by Type

5.3 Americas Companion Diagnostic Tests Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Companion Diagnostic Tests Market Size by Regions

6.2 APAC Companion Diagnostic Tests Market Size by Type

6.3 APAC Companion Diagnostic Tests Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Companion Diagnostic Tests by Countries

7.2 Europe Companion Diagnostic Tests Market Size by Type

7.3 Europe Companion Diagnostic Tests Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Companion Diagnostic Tests by Countries

8.2 Middle East & Africa Companion Diagnostic Tests Market Size by Type

8.3 Middle East & Africa Companion Diagnostic Tests Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Companion Diagnostic Tests Market Forecast

10.1 Global Companion Diagnostic Tests Market Size Forecast (2021-2025)

10.2 Global Companion Diagnostic Tests Forecast by Regions

10.2.1 Global Companion Diagnostic Tests Forecast by Regions (2021-2025)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Companion Diagnostic Tests Forecast by Type

10.8 Global Companion Diagnostic Tests Forecast by Application

11 Key Players Analysis

11.1 F. Hoffman LA Roche Ltd.

11.1.1 Company Details

11.1.2 Companion Diagnostic Tests Product Offered

11.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.1.4 Main Business Overview

11.1.5 F. Hoffman LA Roche Ltd. News

11.2 QIAGEN, Illumina, Inc.

11.2.1 Company Details

11.2.2 Companion Diagnostic Tests Product Offered

11.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.2.4 Main Business Overview

11.2.5 QIAGEN, Illumina, Inc. News

11.3 Agilent Technologies, Inc.

11.3.1 Company Details

11.3.2 Companion Diagnostic Tests Product Offered

11.3.3 Agilent Technologies, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.3.4 Main Business Overview

11.3.5 Agilent Technologies, Inc. News

11.4 Genomic Health, Inc.

11.4.1 Company Details

11.4.2 Companion Diagnostic Tests Product Offered

11.4.3 Genomic Health, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.4.4 Main Business Overview

11.4.5 Genomic Health, Inc. News

11.5 Abbott

11.5.1 Company Details

11.5.2 Companion Diagnostic Tests Product Offered

11.5.3 Abbott Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.5.4 Main Business Overview

11.5.5 Abbott News

11.6 Siemens Healthcare GmBH

11.6.1 Company Details

11.6.2 Companion Diagnostic Tests Product Offered

11.6.3 Siemens Healthcare GmBH Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.6.4 Main Business Overview

11.6.5 Siemens Healthcare GmBH News

11.7 BioMerieux SA, BioGenex

11.7.1 Company Details

11.7.2 Companion Diagnostic Tests Product Offered

11.7.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.7.4 Main Business Overview

11.7.5 BioMerieux SA, BioGenex News

11.8 Thermo Fisher Scientific, Inc.

11.8.1 Company Details

11.8.2 Companion Diagnostic Tests Product Offered

11.8.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.8.4 Main Business Overview

11.8.5 Thermo Fisher Scientific, Inc. News

11.9 AGENDIA NV

11.9.1 Company Details

11.9.2 Companion Diagnostic Tests Product Offered

11.9.3 AGENDIA NV Companion Diagnostic Tests Revenue, Gross Margin and Market Share (2018-2020)

11.9.4 Main Business Overview

11.9.5 AGENDIA NV News

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Companion Diagnostic Tests Market Size CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Protein Detection

Table 5. Major Players of DNA Detection

Table 6. Major Players of Hybridization

Table 7. Major Players of Biomarker

Table 8. Major Players of Others

Table 9. Companion Diagnostic Tests Market Size by Type (2014-2019) ($ Millions)

Table 10. Global Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

Table 11. Global Companion Diagnostic Tests Market Size by Application (2015-2020) ($ Millions)

Table 12. Global Companion Diagnostic Tests Market Size Market Share by Application (2015-2020)

Table 13. Global Companion Diagnostic Tests Revenue by Players (2018-2020) ($ Millions)

Table 14. Global Companion Diagnostic Tests Revenue Market Share by Players (2018-2020)

Table 15. Global Companion Diagnostic Tests Key Players Head office and Products Offered

Table 16. Companion Diagnostic Tests Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Companion Diagnostic Tests Market Size by Regions 2015-2020 ($ Millions)

Table 20. Global Companion Diagnostic Tests Market Size Market Share by Regions 2015-2020

Table 21. Americas Companion Diagnostic Tests Market Size by Countries (2015-2020) ($ Millions)

Table 22. Americas Companion Diagnostic Tests Market Size Market Share by Countries (2015-2020)

Table 23. Americas Companion Diagnostic Tests Market Size by Type (2015-2020) ($ Millions)

Table 24. Americas Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

Table 25. Americas Companion Diagnostic Tests Market Size by Application (2015-2020) ($ Millions)

Table 26. Americas Companion Diagnostic Tests Market Size Market Share by Application (2015-2020)

Table 27. APAC Companion Diagnostic Tests Market Size by Regions (2015-2020) ($ Millions)

Table 28. APAC Companion Diagnostic Tests Market Size Market Share by Regions (2015-2020)

Table 29. APAC Companion Diagnostic Tests Market Size by Type (2015-2020) ($ Millions)

Table 30. APAC Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

Table 31. APAC Companion Diagnostic Tests Market Size by Application (2015-2020) ($ Millions)

Table 32. APAC Companion Diagnostic Tests Market Size Market Share by Application (2015-2020)

Table 33. Europe Companion Diagnostic Tests Market Size by Countries (2015-2020) ($ Millions)

Table 34. Europe Companion Diagnostic Tests Market Size Market Share by Countries (2015-2020)

Table 35. Europe Companion Diagnostic Tests Market Size by Type (2015-2020) ($ Millions)

Table 36. Europe Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

Table 37. Europe Companion Diagnostic Tests Market Size by Application (2015-2020) ($ Millions)

Table 38. Europe Companion Diagnostic Tests Market Size Market Share by Application (2015-2020)

Table 39. Middle East & Africa Companion Diagnostic Tests Market Size by Countries (2015-2020) ($ Millions)

Table 40. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Countries (2015-2020)

Table 41. Middle East & Africa Companion Diagnostic Tests Market Size by Type (2015-2020) ($ Millions)

Table 42. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

Table 43. Middle East & Africa Companion Diagnostic Tests Market Size by Application (2015-2020) ($ Millions)

Table 44. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Application (2015-2020)

Table 45. Key and Potential Regions of Companion Diagnostic Tests

Table 46. Key Application and Potential Industries of Companion Diagnostic Tests

Table 47. Key Challenges of Companion Diagnostic Tests

Table 48. Key Trends of Companion Diagnostic Tests

Table 49. Global Companion Diagnostic Tests Market Size Forecast by Regions (2021-2025) ($ Millions)

Table 50. Global Companion Diagnostic Tests Market Size Market Share Forecast by Regions

Table 51. Global Companion Diagnostic Tests Market Size Forecast by Type (2021-2025) ($ Millions)

Table 52. Global Companion Diagnostic Tests Market Size Market Share Forecast by Type (2021-2025)

Table 53. Global Companion Diagnostic Tests Market Size Forecast by Application (2021-2025) ($ Millions)

Table 54. Global Companion Diagnostic Tests Market Size Market Share Forecast by Application (2021-2025)

Table 55. F. Hoffman LA Roche Ltd. Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 56. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Offered

Table 57. F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 58. F. Hoffman LA Roche Ltd. Main Business

Table 59. F. Hoffman LA Roche Ltd. Latest Developments

Table 60. QIAGEN, Illumina, Inc. Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 61. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Offered

Table 62. QIAGEN, Illumina, Inc. Main Business

Table 63. QIAGEN, Illumina, Inc. Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 64. QIAGEN, Illumina, Inc. Latest Developments

Table 65. Agilent Technologies, Inc. Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 66. Agilent Technologies, Inc. Companion Diagnostic Tests Product Offered

Table 67. Agilent Technologies, Inc. Main Business

Table 68. Agilent Technologies, Inc. Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 69. Agilent Technologies, Inc. Latest Developments

Table 70. Genomic Health, Inc. Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 71. Genomic Health, Inc. Companion Diagnostic Tests Product Offered

Table 72. Genomic Health, Inc. Main Business

Table 73. Genomic Health, Inc. Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 74. Genomic Health, Inc. Latest Developments

Table 75. Abbott Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 76. Abbott Companion Diagnostic Tests Product Offered

Table 77. Abbott Main Business

Table 78. Abbott Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 79. Abbott Latest Developments

Table 80. Siemens Healthcare GmBH Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 81. Siemens Healthcare GmBH Companion Diagnostic Tests Product Offered

Table 82. Siemens Healthcare GmBH Main Business

Table 83. Siemens Healthcare GmBH Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 84. Siemens Healthcare GmBH Latest Developments

Table 85. BioMerieux SA, BioGenex Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 86. BioMerieux SA, BioGenex Companion Diagnostic Tests Product Offered

Table 87. BioMerieux SA, BioGenex Main Business

Table 88. BioMerieux SA, BioGenex Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 89. BioMerieux SA, BioGenex Latest Developments

Table 90. Thermo Fisher Scientific, Inc. Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 91. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Offered

Table 92. Thermo Fisher Scientific, Inc. Main Business

Table 93. Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 94. Thermo Fisher Scientific, Inc. Latest Developments

Table 95. AGENDIA NV Details, Company Total Revenue (in $ million), Head Office, Companion Diagnostic Tests Major Market Areas and Its Competitors

Table 96. AGENDIA NV Companion Diagnostic Tests Product Offered

Table 97. AGENDIA NV Main Business

Table 98. AGENDIA NV Companion Diagnostic Tests Revenue and Gross Margin (2018-2020E)

Table 99. AGENDIA NV Latest Developments

List of Figures

Figure 1. Companion Diagnostic Tests Report Years Considered

Figure 2. Market Research Methodology

Figure 3. Global Companion Diagnostic Tests Market Size Growth Rate 2015-2025 ($ Millions)

Figure 4. Global Companion Diagnostic Tests Market Size Market Share by Type (2015-2020)

Figure 5. Global Protein Detection Market Size Growth Rate

Figure 6. Global DNA Detection Market Size Growth Rate

Figure 7. Global Hybridization Market Size Growth Rate

Figure 8. Global Biomarker Market Size Growth Rate

Figure 9. Global Others Market Size Growth Rate

Figure 10. Companion Diagnostic Tests in Pharmaceutical and Biotechnology Companies

Figure 11. Global Companion Diagnostic Tests Market: Pharmaceutical and Biotechnology Companies (2015-2020) ($ Millions)

Figure 12. Companion Diagnostic Tests in Medical Device Companies

Figure 13. Global Companion Diagnostic Tests Market: Medical Device Companies (2015-2020) ($ Millions)

Figure 14. Companion Diagnostic Tests in Research Institutes

Figure 15. Global Companion Diagnostic Tests Market: Research Institutes (2015-2020) ($ Millions)

Figure 16. Global Research Institutes YoY Growth ($ Millions)

Figure 17. Global Companion Diagnostic Tests Market Size Market Share by Application in 2019

Figure 18. Global Companion Diagnostic Tests Market Size Market Share by Regions 2015-2020

Figure 19. Americas Companion Diagnostic Tests Market Size 2015-2020 ($ Millions)

Figure 20. APAC Companion Diagnostic Tests Market Size 2015-2020 ($ Millions)

Figure 21. Europe Companion Diagnostic Tests Market Size 2015-2020 ($ Millions)

Figure 22. Middle East & Africa Companion Diagnostic Tests Market Size 2015-2020 ($ Millions)

Figure 23. Americas Companion Diagnostic Tests Market Size Market Share by Countries in 2019

Figure 24. Americas Companion Diagnostic Tests Market Size Market Share by Type in 2019

Figure 25. Americas Companion Diagnostic Tests Market Size Market Share by Application in 2019

Figure 26. United States Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 27. Canada Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 28. Mexico Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 29. APAC Companion Diagnostic Tests Market Size Market Share by Regions in 2019

Figure 30. APAC Companion Diagnostic Tests Market Size Market Share by Type in 2019

Figure 31. APAC Companion Diagnostic Tests Market Size Market Share by Application in 2019

Figure 32. China Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 33. Japan Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 34. Korea Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 35. Southeast Asia Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 36. India Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 37. Australia Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 38. Europe Companion Diagnostic Tests Market Size Market Share by Countries in 2019

Figure 39. Europe Companion Diagnostic Tests Market Size Market Share by Type in 2019

Figure 40. Europe Companion Diagnostic Tests Market Size Market Share by Application in 2019

Figure 41. Germany Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 42. France Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 43. UK Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 44. Italy Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 45. Russia Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 46. Spain Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 47. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Countries in 2019

Figure 48. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Type in 2019

Figure 49. Middle East & Africa Companion Diagnostic Tests Market Size Market Share by Application in 2019

Figure 50. Egypt Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 51. South Africa Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 52. Israel Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 53. Turkey Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 54. GCC Countries Companion Diagnostic Tests Market Size Growth 2015-2020 ($ Millions)

Figure 55. Global Companion Diagnostic Tests arket Size Forecast (2021-2025) ($ Millions)

Figure 56. Americas Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 57. APAC Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 58. Europe Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 59. Middle East & Africa Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 60. United States Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 61. Canada Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 62. Mexico Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 63. Brazil Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 64. China Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 65. Japan Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 66. Korea Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 67. Southeast Asia Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 68. India Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 69. Australia Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 70. Germany Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 71. France Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 72. UK Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 73. Italy Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 74. Russia Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 75. Spain Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 76. Egypt Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 77. South Africa Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 78. Israel Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 79. Turkey Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Figure 80. GCC Countries Companion Diagnostic Tests Market Size 2021-2025 ($ Millions)

Sample Request is not available